发明名称 |
Mucosal formulation |
摘要 |
Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s). |
申请公布号 |
US8852652(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US201213691958 |
申请日期 |
2012.12.03 |
申请人 |
Izun Pharmaceuticals, Inc. |
发明人 |
Loewy Zvi G.;Levine William Zev;Saffer Aron J. |
分类号 |
A01N65/00;A61K36/28;A61K36/35;A61K36/23 |
主分类号 |
A01N65/00 |
代理机构 |
Moser Taboada |
代理人 |
Moser Taboada |
主权项 |
1. A method of treating or ameliorating an indication of anal or vaginal mucosal tissue comprising periodically applying to anal or vaginal mucosa at or adjacent to disease affected tissue a formulation comprising
an antiinflammatory effective amount of herbal extracts including Sambucus nigra, Centella asiatica and Echinacea purpurea defining a weight amount of plant extract solids in the formulation, wherein Sambucus nigra extract is more than 50% to 90% by weight of the plant extract solids and Centella asiatica is 1% to less than 50% by weight of the plant extract solids, a plasticizer in an amount from 10 to 45% by weight of the formulation, and an antimicrobially effective amount of a surfactant that is a 1-alkylpyridinium salt, where alkyl is C8-C36, the surfactant present in an amount from 0.01 to 2% of the formulation by weight. |
地址 |
New York NY US |